Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2003
03/18/2003US6534482 Expression vectors for stimulating an immune response and methods of using the same
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534065 Influenza vaccine composition with chitosan adjuvant
03/18/2003US6534064 Herpes simplex virus type 2 glycoprotein B, hepatitis C virus or a human immunodeficiency virus protein as an antigen
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534058 Anti-C5 monoclonal antibodies
03/18/2003US6534054 Probiotic/therapeutic uses of nonpathogenic probiobiotic microorganisms; manufacturing the formulation from the plant derived material
03/18/2003US6534053 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
03/18/2003CA2141048C Substituted benzylamino nitrogen containing non-aromatic heterocycles
03/18/2003CA2121370C Specific tolerance in transplantation
03/14/2003WO2002026710A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
03/14/2003CA2422613A1 5-phenylbenzylamine compound, process for preparing the same and synthetic intermediate thereof
03/13/2003WO2003021262A1 Screening method
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020769A1 Pemphigus monoclonal antibody
03/13/2003WO2003020767A2 Antibodies against caspase-8, their preparation and use
03/13/2003WO2003020763A2 Soluble t cell receptor
03/13/2003WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020747A1 Modified peptides and their use for the treatment of autoimmune diseases
03/13/2003WO2003020731A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/13/2003WO2003020724A1 Polycyclic guanine phosphodiesterase v inhibitors
03/13/2003WO2003020722A1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
03/13/2003WO2003020721A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases
03/13/2003WO2003020716A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003WO2003020703A1 Cyclic amine compound
03/13/2003WO2003020320A2 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003WO2003020306A1 Desensitizers
03/13/2003WO2003020295A1 Remedies or preventives for allergic diseases comprising processed peanut seed coat
03/13/2003WO2003020290A1 Therapeutic process for p. aeruginosa infections using macrolide antibiotics
03/13/2003WO2003020278A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
03/13/2003WO2003020275A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders
03/13/2003WO2003020253A2 Pharmaceutical compositions for the treatment of asthma
03/13/2003WO2003020241A2 Functional powders for oral delivery
03/13/2003WO2003020219A2 Aerosolized decongestants for the treatment of sinusitis
03/13/2003WO2002100354A3 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
03/13/2003WO2002098397A3 Therapeutic compositions for modulating the immune response in a mammal and use thereof
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002096447A3 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
03/13/2003WO2002089796A3 Methods for selective immunomodulation using pimecrolimus
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002078742A3 Methods and compositions for treatment of immune dysfunction disorders
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002074726A3 Aniline derivatives useful as phosphodiesterase 4 inhibitors
03/13/2003WO2002072543A3 Rxr activating molecules
03/13/2003WO2002068654A3 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
03/13/2003WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/13/2003WO2002067760A3 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
03/13/2003WO2002066059A8 Agents that specifically block cd28-mediated signaling and uses therefor
03/13/2003WO2002063012A3 Ragweed allergens
03/13/2003WO2002053519A3 Hydrophobic polyamine analogs and methods for their use
03/13/2003WO2002053180A3 Immunizing compositions and methods of use
03/13/2003WO2002050019A3 Diamines as modulators of chemokine receptor activity
03/13/2003WO2002046191A3 Urea substituted imidazoquinoline ethers
03/13/2003WO2002046188A3 Amido ether substituted imidazoquinolines
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002044364A3 Polypeptides involved in immune response
03/13/2003WO2002044128A3 Salicylate analogs as interleukin-4 antagonists
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002038140A3 Therapeutic uses for ip3 receptor-mediated calcium channel modulators
03/13/2003WO2002034290A3 Antibodies and other ligands directed against kir2dl4 receptor for production of interferon gamma
03/13/2003WO2002034288A3 Vaccine for treating allergy
03/13/2003WO2002031511A3 Modulation of ligand binding/enzymatic activity of alpha beta proteins
03/13/2003WO2002024233A3 Control of nk cell function and survival by modulation of ship activity
03/13/2003WO2002024194A3 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
03/13/2003WO2002022563A1 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
03/13/2003WO2002022151A3 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/13/2003WO2002017959A3 Immunosuppression using piceatannol and a calcineurin inhibitor
03/13/2003WO2002013866A3 Stimulating neutrophil function to treat inflammatory bowel disease
03/13/2003WO2002010347A3 Directed differentiation of embryonic cells
03/13/2003WO2001082911A3 TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING CLIOQUINOL
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003US20030050469 Induction of a Th1-like response in vitro
03/13/2003US20030050461 Protein for use in the diagnosis, prevention and treatment of metabolic, developmental, nutrient transport and cell proliferation disorders
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050454 Oligonucleotide sfor use in the treatment of cancer and viral diseases
03/13/2003US20030050447 Polypeptide for use in the generation of vaccine against diphtheria toxin
03/13/2003US20030050304 Therapeutic compounds
03/13/2003US20030050303 Treating neutrophils and eosinophils in the tissue of the eye or nasal mucous membrane
03/13/2003US20030050298 A sulfonamide substituted diphenyl thiourea compounds treating a chemokine mediated disease
03/13/2003US20030050279 Beta-glucans
03/13/2003US20030050278 Agent and food for inhibiting IgE antibody
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050261 Immunostimulatory nucleic acid molecules
03/13/2003US20030050244 Controlling the action of cytokines, particularly chemokines, by inhibiting their binding with receptors; used as immunogens for use as metazoan parasite vaccines; antiallergens; veterinary medicine
03/13/2003US20030050235 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator
03/13/2003US20030050230 A nucleic acid encoding a family (title) of kinases from a group of sixteen polypeptides; identifying a substance that modulates kinase activity; autoimmune diseases; organ transplantation, cardiovascular disease, stroke, renal failure
03/13/2003US20030050228 Administering by mouth an effective amount of an insulin polypeptide derivative within one hour of ingestion of a meal by the patient to provide an insulin drug concentration in portal vein blood of 10-1,000 U/ml within 60 minutes
03/13/2003US20030049844 Recombinant canine herpesviruses
03/13/2003US20030049797 Hybrid proteins for autoimmune disease
03/13/2003US20030049791 Goodpasture antigen binding protein
03/13/2003US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049713 Evaluating modulator of kallikrein generation; obtain prekallikrein mixture, incubate with kininogen, phosphate and zinc ions and modulator, monitor adjustment in generation of kallikrein
03/13/2003US20030049706 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of bacterial infections
03/13/2003US20030049691 Nucleotide sequences coding polypeptide for use as diagnostic tool in the detection of allergic response to mammalian animal dander
1 ... 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 ... 1172